P-selectin Inhibitor for the Treatment of Sickle Cell Disease
Application
A glycopeptide inhibitor of p-selectin for the treatment of sickle cell disease.
Key Benefits
Blocks the activity of P-selectin with nM affinity.
Potential treatment for vaso-occlusive crisis associated with sickle cell disease.
Inhibits the earliest stage of leukocyte activation helping to prevent immune response.
Market Summary
Sickle...
Published: 4/8/2024
Contributor(s): Richard Cummings, Elliot Chaikof, Venkata Krishnamurthy, Mohammed Sardar
|